
Scott Long
Examiner (ID: 10754, Phone: (571)272-9048 , Office: P/1633 )
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1633 |
| Total Applications | 882 |
| Issued Applications | 557 |
| Pending Applications | 29 |
| Abandoned Applications | 301 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5443064
[patent_doc_number] => 20090094703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-09
[patent_title] => 'Novel medulloblastoma-forming cell line'
[patent_app_type] => utility
[patent_app_number] => 12/230809
[patent_app_country] => US
[patent_app_date] => 2008-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4340
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20090094703.pdf
[firstpage_image] =>[orig_patent_app_number] => 12230809
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/230809 | Novel medulloblastoma-forming cell line | Sep 4, 2008 | Abandoned |
Array
(
[id] => 8543623
[patent_doc_number] => 08318914
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-27
[patent_title] => 'Elongases and methods for producing polyunsaturated fatty acids in transgenic organisms'
[patent_app_type] => utility
[patent_app_number] => 12/671097
[patent_app_country] => US
[patent_app_date] => 2008-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 30716
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12671097
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/671097 | Elongases and methods for producing polyunsaturated fatty acids in transgenic organisms | Jul 29, 2008 | Issued |
Array
(
[id] => 6416637
[patent_doc_number] => 20100306863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-02
[patent_title] => 'SCREENING, THERAPY AND DIAGNOSIS'
[patent_app_type] => utility
[patent_app_number] => 12/452813
[patent_app_country] => US
[patent_app_date] => 2008-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 27763
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20100306863.pdf
[firstpage_image] =>[orig_patent_app_number] => 12452813
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/452813 | SCREENING, THERAPY AND DIAGNOSIS | Jul 22, 2008 | Abandoned |
Array
(
[id] => 14323253
[patent_doc_number] => 10292619
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-21
[patent_title] => Patient breathing modeling
[patent_app_type] => utility
[patent_app_number] => 12/170385
[patent_app_country] => US
[patent_app_date] => 2008-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 19
[patent_no_of_words] => 6427
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12170385
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/170385 | Patient breathing modeling | Jul 8, 2008 | Issued |
Array
(
[id] => 6340487
[patent_doc_number] => 20100247601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'REPAIR AND TREATMENT OF BONE DEFECT USING CELLS INDUCED BY AGENT PRODUCED BY CHONDROCYTES CAPABLE OF HYPERTROPHICATION AND SCAFFOLD'
[patent_app_type] => utility
[patent_app_number] => 12/665317
[patent_app_country] => US
[patent_app_date] => 2008-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 60
[patent_no_of_words] => 67787
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20100247601.pdf
[firstpage_image] =>[orig_patent_app_number] => 12665317
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/665317 | REPAIR AND TREATMENT OF BONE DEFECT USING CELLS INDUCED BY AGENT PRODUCED BY CHONDROCYTES CAPABLE OF HYPERTROPHICATION AND SCAFFOLD | Jun 19, 2008 | Abandoned |
Array
(
[id] => 9059453
[patent_doc_number] => 08545888
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-01
[patent_title] => 'Tendon stem cells'
[patent_app_type] => utility
[patent_app_number] => 12/663663
[patent_app_country] => US
[patent_app_date] => 2008-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 45
[patent_no_of_words] => 19168
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12663663
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/663663 | Tendon stem cells | Jun 12, 2008 | Issued |
Array
(
[id] => 4710578
[patent_doc_number] => 20080299104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'METHODS FOR DETECTING AGENTS INVOLVED IN NEURONAL APOPTOSIS AND COMPOSITIONS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/126691
[patent_app_country] => US
[patent_app_date] => 2008-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 31317
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20080299104.pdf
[firstpage_image] =>[orig_patent_app_number] => 12126691
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/126691 | METHODS FOR DETECTING AGENTS INVOLVED IN NEURONAL APOPTOSIS AND COMPOSITIONS THEREOF | May 22, 2008 | Abandoned |
Array
(
[id] => 8845778
[patent_doc_number] => 08454954
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-04
[patent_title] => 'Treatment of synucleinopathies'
[patent_app_type] => utility
[patent_app_number] => 12/600141
[patent_app_country] => US
[patent_app_date] => 2008-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 12
[patent_no_of_words] => 18273
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12600141
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/600141 | Treatment of synucleinopathies | May 15, 2008 | Issued |
Array
(
[id] => 6230316
[patent_doc_number] => 20100184214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'METHOD FOR PRODUCTION OF DENDRITIC CELL'
[patent_app_type] => utility
[patent_app_number] => 12/600103
[patent_app_country] => US
[patent_app_date] => 2008-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 18816
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20100184214.pdf
[firstpage_image] =>[orig_patent_app_number] => 12600103
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/600103 | Method for production of dendritic cell | May 11, 2008 | Issued |
Array
(
[id] => 4778248
[patent_doc_number] => 20080286246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient'
[patent_app_type] => utility
[patent_app_number] => 12/149646
[patent_app_country] => US
[patent_app_date] => 2008-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 70
[patent_figures_cnt] => 70
[patent_no_of_words] => 38089
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20080286246.pdf
[firstpage_image] =>[orig_patent_app_number] => 12149646
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/149646 | Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient | May 5, 2008 | Issued |
Array
(
[id] => 8232638
[patent_doc_number] => 08198079
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-12
[patent_title] => 'Synthetic expression vectors for insect cells'
[patent_app_type] => utility
[patent_app_number] => 12/451145
[patent_app_country] => US
[patent_app_date] => 2008-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 15459
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/198/08198079.pdf
[firstpage_image] =>[orig_patent_app_number] => 12451145
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/451145 | Synthetic expression vectors for insect cells | Apr 27, 2008 | Issued |
Array
(
[id] => 6339407
[patent_doc_number] => 20100199362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'WNT LIGANDS INVOLVED IN BLOOD-BRAIN BARRIER DEVELOPMENT AND USES THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 12/597669
[patent_app_country] => US
[patent_app_date] => 2008-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 17237
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20100199362.pdf
[firstpage_image] =>[orig_patent_app_number] => 12597669
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/597669 | WNT LIGANDS INVOLVED IN BLOOD-BRAIN BARRIER DEVELOPMENT AND USES THEREFOR | Apr 27, 2008 | Abandoned |
Array
(
[id] => 6390954
[patent_doc_number] => 20100303714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-02
[patent_title] => 'ONCOLYTIC VACCINIA VIRUS CANCER THERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/531353
[patent_app_country] => US
[patent_app_date] => 2008-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 38808
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0303/20100303714.pdf
[firstpage_image] =>[orig_patent_app_number] => 12531353
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/531353 | ONCOLYTIC VACCINIA VIRUS CANCER THERAPY | Mar 16, 2008 | Abandoned |
Array
(
[id] => 4739932
[patent_doc_number] => 20080233585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'USE OF DIFFERENTIALLY EXPRESSED NUCLEIC ACID SEQUENCES AS BIOMARKERS FOR CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/047358
[patent_app_country] => US
[patent_app_date] => 2008-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26795
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20080233585.pdf
[firstpage_image] =>[orig_patent_app_number] => 12047358
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/047358 | USE OF DIFFERENTIALLY EXPRESSED NUCLEIC ACID SEQUENCES AS BIOMARKERS FOR CANCER | Mar 12, 2008 | Abandoned |
Array
(
[id] => 6348381
[patent_doc_number] => 20100021443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'METHOD OF PREPARING LUNG ALVEOLAR EPITHELIAL TYPE II CELLS DERIVED FROM EMBRYONIC STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/527969
[patent_app_country] => US
[patent_app_date] => 2008-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7170
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20100021443.pdf
[firstpage_image] =>[orig_patent_app_number] => 12527969
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/527969 | Method of preparing lung alveolar epithelial type II cells derived from embryonic stem cells | Feb 20, 2008 | Issued |
Array
(
[id] => 6313797
[patent_doc_number] => 20100111873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'TREATING CANCER WITH VIRAL NUCLEIC ACID'
[patent_app_type] => utility
[patent_app_number] => 12/528047
[patent_app_country] => US
[patent_app_date] => 2008-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 14056
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20100111873.pdf
[firstpage_image] =>[orig_patent_app_number] => 12528047
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/528047 | TREATING CANCER WITH VIRAL NUCLEIC ACID | Feb 19, 2008 | Abandoned |
Array
(
[id] => 8981580
[patent_doc_number] => 08512693
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-20
[patent_title] => 'Self-assembling membranes and related methods thereof'
[patent_app_type] => utility
[patent_app_number] => 12/031421
[patent_app_country] => US
[patent_app_date] => 2008-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9888
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12031421
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/031421 | Self-assembling membranes and related methods thereof | Feb 13, 2008 | Issued |
Array
(
[id] => 4493330
[patent_doc_number] => 07956036
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-07
[patent_title] => 'Polypeptide and DNA thereof useful as a neovascular marker'
[patent_app_type] => utility
[patent_app_number] => 12/027873
[patent_app_country] => US
[patent_app_date] => 2008-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 21203
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/956/07956036.pdf
[firstpage_image] =>[orig_patent_app_number] => 12027873
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/027873 | Polypeptide and DNA thereof useful as a neovascular marker | Feb 6, 2008 | Issued |
Array
(
[id] => 6631451
[patent_doc_number] => 20100100977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'PROBE FOR VISUALIZING CELL-CYCLE'
[patent_app_type] => utility
[patent_app_number] => 12/450155
[patent_app_country] => US
[patent_app_date] => 2008-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13057
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20100100977.pdf
[firstpage_image] =>[orig_patent_app_number] => 12450155
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/450155 | Probe for visualizing cell-cycle | Feb 5, 2008 | Issued |
Array
(
[id] => 5545907
[patent_doc_number] => 20090155784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'ASSESSMENT OF ASTHMA AND ALLERGEN-DEPENDENT GENE EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 12/017178
[patent_app_country] => US
[patent_app_date] => 2008-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 44224
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20090155784.pdf
[firstpage_image] =>[orig_patent_app_number] => 12017178
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/017178 | ASSESSMENT OF ASTHMA AND ALLERGEN-DEPENDENT GENE EXPRESSION | Jan 20, 2008 | Abandoned |